Answers are grounded in this paper and cite their sources.
Anti-certolizumab antibodies were detected in a large proportion of patients, but in most cases where ADAs were detected, certolizumab was also present in high concentrations, directly correlating with in vitro neutralising capacity. These results indicate that measurement of certolizumab drug levels, rather than ADAs, have direct clinical significance.
No takes yet. Share an insight, caveat, or question.
Berkhout et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: